C30H29ClN6O4
Neat
573.05
Room Temperature
Neratinib pyridine N-oxide; 1376619-94-1; Neratinib metabolite M3; PO13R2U9YB; HKI-272 pyridine N-oxide; WYE-121529; 2-Butenamide, N-(4-((3-chloro-4-((1-oxido-2-pyridinyl)methoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)- and (2E)-; RefChem:1092333; UNII-PO13R2U9YB; (E)-2-((2-Chloro-4-((3-cyano-6-(4-(dimethylamino)but-2-enamido)-7-ethoxyquinolin-4-yl)amino)phenoxy)methyl)pyridine 1-oxide; (E)-N-[4-[3-chloro-4-[(1-oxidopyridin-1-ium-2-yl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide; Neratinib Pyridine-N-oxide (M3); Neratinib Impurity 16; CS-0165599; (E)-2-((2-chloro-4-((3-cyano-6-(4-(dimethylamino)but-2-enamido)-7-ethoxyquinolin-4-yl)amino)phenoxy)methyl)pyridine 1-oxide? (Neratinib Impurity pound(c)
(E)-N-[4-[3-chloro-4-[(1-oxidopyridin-1-ium-2-yl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
InChI=1S/C30H29ClN6O4/c1-4-40-28-16-25-23(15-26(28)35-29(38)9-7-12-36(2)3)30(20(17-32)18-33-25)34-21-10-11-27(24(31)14-21)41-19-22-8-5-6-13-37(22)39/h5-11,13-16,18H,4,12,19H2,1-3H3,(H,33,34)(H,35,38)/b9-7+